Erratum in: Review of the Treatment of Non-Small Cell Lung Cancer with Gefitinib

Erratum in: Review of the Treatment of Non-Small Cell Lung Cancer with Gefitinib

Show other versions (1)

Bibliographic Details
Main Authors:	Takuya Araki, Hideaki Yashima, Kimihiro Shimizu, Tohru Aomori, Tadahiro Hashita, Kyoichi Kaira, Tomonori Nakamura, Koujirou Yamamoto
Format:	Article
Language:	English
Published:	SAGE Publishing 2013-05-01
Series:	Clinical Medicine Insights: Oncology
Online Access:	http://www.la-press.com/erratum-in-review-of-the-treatment-of-non-small-cell-lung-cancer-with--article-a3683

Similar Items

Erratum in: Review of the Treatment of Non-Small Cell Lung Cancer with Gefitinib
by: Takuya Araki, et al.
Published: (2013-01-01)

Review of the Treatment of Non-Small Cell Lung Cancer with Gefitinib
by: Takuya Araki, et al.
Published: (2012-12-01)

Review of the Treatment of Non-Small Cell Lung Cancer with Gefitinib
by: Takuya Araki, et al.
Published: (2012-01-01)

Clinical application for determination of darunavir using very limited volume of plasma by high-performance liquid chromatography with fluorescence detection
by: Daisuke Nagano, et al.
Published: (2012-01-01)

Effect of atypical antipsychotics on glucose and lipid metabolism
by: Madoka Fujimaki, et al.
Published: (2012-01-01)

Comparison of the vkor inhibitory activities by S- and R -warfarin
by: Masashi Kawano, et al.
Published: (2012-01-01)

Gefitinib in Non Small Cell Lung Cancer
by: Raffaele Costanzo, et al.
Published: (2011-01-01)

PK/PD of warfarin associated with genetic polymorphisms of VKORC1 and CYP2C9 in indonesian patients
by: Taofik Rusdiana, et al.
Published: (2012-01-01)

Effect of milk thistle (silybum marianum) on glucose and lipid metabolism
by: Yukina Nakagome, et al.
Published: (2012-01-01)

Clinical benefit of readministration of gefitinib for initial gefitinib-responders with non-small cell lung cancer
by: Harada Masao, et al.
Published: (2007-03-01)

Gefitinib in Advanced Non-small-cell Lung Cancer
by: Zhenjun YANG, et al.
Published: (2009-05-01)

Choroidal Metastasis of Non-Small Cell Lung Cancer That Responded to Gefitinib
by: Iwao Shimomura, et al.
Published: (2013-01-01)

Gefitinib for Non-small Cell Lung Cancer: A meta Analysis
by: Jiwu GUO, et al.
Published: (2011-04-01)

Optimizing response to gefitinib in the treatment of non-small-cell lung cancer
by: Pietro Carotenuto, et al.
Published: (2011-03-01)

Critical Appraisal of Gefitinib in the Treatment of Non-Small Cell Lung Cancer
by: Yung-Hung Luo, et al.
Published: (2015-09-01)

Absolute Lymphocyte Count Predicts Immune-Related Adverse Events in Patients With Non-Small-Cell Lung Cancer Treated With Nivolumab Monotherapy: A Multicenter Retrospective Study
by: Saeka Egami, et al.
Published: (2021-05-01)

Polyphyllin VII increases sensitivity to gefitinib by modulating the elevation of P21 in acquired gefitinib resistant non-small cell lung cancer
by: Honggang Wang, et al.
Published: (2017-07-01)

Chloroquine enhances gefitinib cytotoxicity in gefitinib-resistant nonsmall cell lung cancer cells.
by: Mei-Chuan Tang, et al.
Published: (2015-01-01)

Effects of BTK inhibitor on gefitinib-resistant non-small cell lung cancer
by: Yu-TiFang, et al.
Published: (2017)

Emerging role of gefitinib in the treatment of non-small-cell lung cancer (NSCLC)
by: M Tiseo, et al.
Published: (2010-05-01)

Management of patients with advanced non-small cell lung cancer: role of gefitinib
by: Vamsidhar Velcheti, et al.
Published: (2010-04-01)

Efficacy of PD-1 blockade therapy and T cell immunity in lung cancer patients
by: Hiroshi Kagamu, et al.
Published: (2020-01-01)

Prognostic value of metabolic tumor volume of pretreatment 18F-FAMT PET/CT in non-small cell lung Cancer
by: Soma Kumasaka, et al.
Published: (2018-11-01)

Pharmacokinetics of Gefitinib in a Patient with Non-Small Cell Lung Cancer Undergoing Continuous Ambulatory Peritoneal Dialysis
by: Teppei Yamaguchi, et al.
Published: (2015-02-01)

FOXC1 Knockdown Reverses Gefitinib Resistance in Non-small Cell Lung Cancer
by: Cong PENG, et al.
Published: (2021-08-01)

GEFITINIB (IRESSA) IN THE TREATMENT OF BRAIN METASTASES FROM NON-SMALL CELL LUNG CARCINOMA
by: D. R. Naskhletashvili, et al.
Published: (2015-04-01)

Clinical Observation of Gefitinib with Pericardial Perfusion for  Advanced Non-small Cell Lung Cancer
by: Xiaomeng WANG, et al.
Published: (2018-01-01)

Role of gefitinib in the targeted treatment of non-small-cell lung cancer in Chinese patients
by: Li MJ, et al.
Published: (2016-03-01)

Gefitinib Monotherapy in Advanced non-small-cell Lung Cancer: A Retrospective Analysis
by: S Shrestha, et al.
Published: (2012-06-01)

Implications of MicroRNAs in the Treatment of Gefitinib-Resistant Non-Small Cell Lung Cancer
by: Thomas K. Sin, et al.
Published: (2016-02-01)

Interferon-α reduces the gefitinib sensitivity of human non-small cell lung cancer
by: Chi Pan, et al.
Published: (2016-09-01)

Molecular Factors Related to Gefitinib Efficacy in Advanced Non-small Cell Lung Cancer
by: Tao ZHOU, et al.
Published: (2010-03-01)

Losmapimod Overcomes Gefitinib Resistance in Non-small Cell Lung Cancer by Preventing Tetraploidization
by: Yiu To Yeung, et al.
Published: (2018-02-01)

Response to gefitinib and erlotinib in Non-small cell lung cancer: a restrospective study
by: Auclair Paul L, et al.
Published: (2009-09-01)

Icotinib is as efficacious as gefitinib for brain metastasis of EGFR mutated non-small-cell lung cancer
by: Kejun Liu, et al.
Published: (2020-01-01)

Skin manifestations of gefitinib and the association with survival of advanced non-small-cell lung cancer in Taiwan
by: Shiou-Han Wang, et al.
Published: (2011-03-01)

Correlation between DAPK Promoter Methylation and Gefitinib Sensitivity in Non-small Cell Lung Cancer
by: Weiqin Wu, et al.
Published: (2013-12-01)

Evaluation of Efficacy of Gefitinib on Advanced non-small-cell Lung Cancer (NSCLC) Resisted to Chemotherapy
by: Jiangjiang TU, et al.
Published: (2008-04-01)

A comparative study on erlotinib & gefitinib therapy in non-small cell lung carcinoma patients
by: Preenumol Thomas, et al.
Published: (2019-01-01)

Gefitinib for the first-line treatment of locally advanced or metastatic non-small cell lung cancer
by: T Brown, et al.
Published: (2010-10-01)